Substrates for peptidase M34.001: anthrax lethal factor
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dual specificity mitogen-activated protein kinase kinase 1 | Q02750 | 2-393 | peptide-Pro8+Ile-peptide | N | Lys | Pro | Thr | Pro | Ile | Gln | Leu | Asn | Vitale et al., 2000 | 17103 | ||
| dual specificity mitogen-activated protein kinase kinase 2 | P36507 | 1-400 | peptide-Pro10+Ala-peptide | N | Pro | Val | Leu | Pro | Ala | Leu | Thr | Ile | Vitale et al., 2000 | 17105 | ||
| Dual specificity mitogen-activated protein kinase kinase 7 | O14733 | 1-419 | peptide-Gln44+Leu-peptide | N | Pro | Thr | Leu | Gln | Leu | Pro | Leu | Ala | Vitale et al., 2000 | 17109 | ||
| Dual specificity mitogen-activated protein kinase kinase 7 | O14733 | 1-419 | peptide-Glu76+Leu-peptide | N | His | Met | Leu | Gly | Leu | Pro | Ser | Thr | Vitale et al., 2000 | 17110 | ||
| Mca-Lys-Lys-Pro-Thr-Pro-Ile-Gln-Leu-Asn-Dnp | Mca-Lys-Lys-Pro-Thr-Pro+Ile-Gln-Leu-Asn-Dnp | S | Lys | Pro | Thr | Pro | Ile | Gln | Leu | Asn | Li et al., 2011 | |||||
| Mca-Lys-Lys-Trp-Leu-Met-Tyr-Pro-Leu-Glu-Lys-Dnp | Mca-Lys-Lys-Trp-Leu-Met+Tyr-Pro-Leu-Glu-Lys-Dnp | S | Lys | Trp | Leu | Met | Tyr | Pro | Leu | Glu | Li et al., 2011 | |||||
| Mca-Lys-Lys-Val-Tyr-Pro-Tyr-Pro-Met-Glu-Lys-Dnp | Mca-Lys-Lys-Val-Tyr-Pro+Tyr-Pro-Met-Glu-Lys-Dnp | S | Lys | Val | Tyr | Pro | Tyr | Pro | Met | Glu | Li et al., 2011 | |||||
| mitogen-activated protein kinase kinase 1 | Q05116 | 2-395 | peptide-Pro8+Thr-peptide | N | Lys | Pro | Thr | Pro | Ile | Gln | Leu | Asn | Duesbery et al., 1998 | |||
| mitogen-activated protein kinase kinase MKK3b | P46734 | 1-347 | peptide-Arg26+Ile-peptide | N | Lys | Asp | Leu | Arg | Ile | Ser | Cys | Met | Vitale et al., 2000 | 17106 | ||
| mitogen-activated protein kinase kinase MKK4 | P45985 | 1-399 | peptide-Lys45+Leu-peptide | N | Lys | Ala | Leu | Lys | Leu | Asn | Phe | Ala | Vitale et al., 2000 | 17107 | ||
| mitogen-activated protein kinase kinase MKK4 | P45985 | 1-399 | peptide-Arg58+Phe-peptide | N | Ser | Thr | Ala | Arg | Phe | Thr | Leu | Asn | Vitale et al., 2001 | 19465 | ||
| mitogen-activated protein kinase kinase MKK6b | P52564 | 1-334 | peptide-Arg14+Ile-peptide | N | Pro | Gly | Leu | Lys | Ile | Pro | Lys | Glu | Vitale et al., 2000 | 17108 | ||
| NACHT, LRR and PYD domains-containing protein 1b allele 1 | Q2LKW6 | 1-1233 | peptide-Lys38+Leu-peptide | P | NT | His | Arg | Pro | Lys | Leu | Glu | Arg | His | Mendenhall et al., 2020 | ||
| NACHT, LRR and PYD domains-containing protein 1b allele 1 | Q2LKW6 | 1-1233 | peptide-Lys44+Leu-peptide | P | NT | Arg | His | Leu | Lys | Leu | Gly | Met | Ile | Mendenhall et al., 2020 | ||
| nLR family, pyrin domain-containing 1A | D9I2F9 | 1-1218 | peptide-Pro44+Leu-peptide | P | NT | Arg | Pro | Arg | Pro | Leu | Pro | Arg | Val | Mendenhall et al., 2020 | ||
| phosphatidylinositol 3-kinase regulatory subunit alpha | P27986 | 2-724 | peptide-Pro94+Leu-peptide | P | NT | Pro | Pro | Arg | Pro | Leu | Pro | Val | Ala | Mendenhall et al., 2020 | ||
| phosphatidylinositol 3-kinase regulatory subunit beta | O00459 | 1-728 | peptide-Pro95+Leu-peptide | P | NT | Gly | Pro | Arg | Pro | Leu | Pro | Ala | Arg | Mendenhall et al., 2020 |
